Royal Bank of Canada »

Bright Minds Biosciences shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 278 0.00
2023-09-30 $0 96 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
UnitedHealth (UNH)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Bright Minds Biosciences

Hrt Financial
Virtu Financial
UBS Group
Royal Bank of Canada
Aspire Private Capital

View all funds holding Bright Minds Biosciences